Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Nighttime awakenings responding to gabapentin therapy in late premenopausal women: a case series.

Guttuso T Jr.

J Clin Sleep Med. 2012 Apr 15;8(2):187-9. doi: 10.5664/jcsm.1776.

2.
3.

A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep.

Joffe H, Crawford S, Economou N, Kim S, Regan S, Hall JE, White D.

Sleep. 2013 Dec 1;36(12):1977-85. doi: 10.5665/sleep.3244.

4.

The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.

Hickey M, Emery LI, Gregson J, Doherty DA, Saunders CM.

Menopause. 2010 Jul;17(4):727-33. doi: 10.1097/gme.0b013e3181d672f6.

PMID:
20512079
5.

Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms.

Lampio L, Polo-Kantola P, Polo O, Kauko T, Aittokallio J, Saaresranta T.

Menopause. 2014 Nov;21(11):1217-24. doi: 10.1097/GME.0000000000000239.

PMID:
24755900
6.

Gabapentin improves sleep in the presence of alcohol.

Bazil CW, Battista J, Basner RC.

J Clin Sleep Med. 2005 Jul 15;1(3):284-7.

PMID:
17566190
7.

Gabapentin shows promise in treating refractory insomnia in children.

Robinson AA, Malow BA.

J Child Neurol. 2013 Dec;28(12):1618-21. doi: 10.1177/0883073812463069. Epub 2012 Oct 30.

PMID:
23112238
8.

Treatment effects of gabapentin for primary insomnia.

Lo HS, Yang CM, Lo HG, Lee CY, Ting H, Tzang BS.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):84-90. doi: 10.1097/WNF.0b013e3181cda242.

PMID:
20124884
9.

Correlation between climacteric symptoms and serum levels of estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone.

Abe T, Furuhashi N, Yamaya Y, Wada Y, Hoshiai A, Suzuki M.

Am J Obstet Gynecol. 1977 Sep 1;129(1):65-7.

PMID:
900171
10.

Letter regarding "Treatment effects of gabapentin for primary insomnia".

Hamer RM, Simpson PM.

Clin Neuropharmacol. 2011 May-Jun;34(3):133. doi: 10.1097/WNF.0b013e31821f4a23. No abstract available.

PMID:
21586921
11.

Assessment and treatment of hot flushes and menopausal mood disturbance.

Joffe H, Soares CN, Cohen LS.

Psychiatr Clin North Am. 2003 Sep;26(3):563-80. Review.

PMID:
14563098
12.

Gabapentin in the treatment of dementia-associated nocturnal agitation.

Buskova J, Busek P, Nevsimalova S.

Med Sci Monit. 2011 Dec;17(12):CS149-51.

13.

Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model.

Yurcheshen ME, Guttuso T Jr, McDermott M, Holloway RG, Perlis M.

J Womens Health (Larchmt). 2009 Sep;18(9):1355-60. doi: 10.1089/jwh.2008.1257.

PMID:
19708803
14.

Associations of hormones and menopausal status with depressed mood in women with no history of depression.

Freeman EW, Sammel MD, Lin H, Nelson DB.

Arch Gen Psychiatry. 2006 Apr;63(4):375-82.

PMID:
16585466
15.

Gabapentin in somatoform and panic disorder.

Joos AA, Zeeck A.

J Clin Psychopharmacol. 2013 Feb;33(1):140-2. doi: 10.1097/01.jcp.0000426187.42045.a3. No abstract available.

PMID:
23288241
16.

Gabapentin for the treatment of recalcitrant chronic prurigo nodularis.

Dereli T, Karaca N, Inanir I, Ozt├╝rk G.

Eur J Dermatol. 2008 Jan-Feb;18(1):85-6. Epub 2007 Dec 18. No abstract available.

PMID:
18086601
17.

Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.

Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS.

Menopause. 2009 Jan-Feb;16(1):50-9. doi: 10.1097/GME.0b013e31817ee0c2.

PMID:
18978637
18.

Use of gabapentin for the management of natural or surgical menopausal hot flashes.

Hayes LP, Carroll DG, Kelley KW.

Ann Pharmacother. 2011 Mar;45(3):388-94. doi: 10.1345/aph.1P366. Epub 2011 Feb 22. Review.

PMID:
21343402
20.

[Use of gabapentin in group B -- DSM-IV personality disorders].

Morana HC, Olivi ML, Daltio CS.

Rev Bras Psiquiatr. 2004 Jun;26(2):136-7. Epub 2004 Oct 27. Portuguese. No abstract available.

Supplemental Content

Support Center